Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus. His cardiovascular risk was > 15%  http://www.cvdcheck.org.au/ His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol.   http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs.  Management of his condition now includes the following: Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013). Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis Medications: Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food ramipril 5 mg, daily Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily Ongoing diagnostics: HbA1c: every 3 months lipid profile: every 3 months renal function assessment: annually podiatrist assessment: at least once a year optometrist assessment: at least once a year   QUESTION: From this list choose metformin therapy to discuss. ANSWER THE  the following  QUESTION  IN DETAIL . 1. refer briefly to any australian GUIDELINES which support the use of metformin medication 2. identify one RISK or special consideration for Mehmet whilst taking metformin. 3. identify what evidence will demonstrate the EFFECTIVENESS of metformin for Mehmet.

Principles Of Pharmacology Med Assist
6th Edition
ISBN:9781337512442
Author:RICE
Publisher:RICE
Chapter24: Medications That Affect The Respiratory System
Section: Chapter Questions
Problem 15RQ
icon
Related questions
Question

Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.

His cardiovascular risk was > 15%  http://www.cvdcheck.org.au/

His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol.  

http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx

He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs.

 Management of his condition now includes the following:

  1. Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week
  2. Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).
  3. Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day
  4. Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis

Medications:

  1. Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food
  2. ramipril 5 mg, daily
  3. Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily

Ongoing diagnostics:

  1. HbA1c: every 3 months
  2. lipid profile: every 3 months
  3. renal function assessment: annually
  4. podiatrist assessment: at least once a year
  5. optometrist assessment: at least once a year

 

QUESTION:

From this list choose metformin therapy to discuss.

ANSWER THE  the following  QUESTION  IN DETAIL .

1. refer briefly to any australian GUIDELINES which support the use of metformin medication

2. identify one RISK or special consideration for Mehmet whilst taking metformin.

3. identify what evidence will demonstrate the EFFECTIVENESS of metformin for Mehmet.

Expert Solution
steps

Step by step

Solved in 4 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Principles Of Pharmacology Med Assist
Principles Of Pharmacology Med Assist
Biology
ISBN:
9781337512442
Author:
RICE
Publisher:
Cengage